Xiao-Fan Zhu
Tianjin, Tianjin Municipality, 300000, China
NCT Number: NCT03595969
Compelling epidemiological evidence indicates that alterations of mitochondrial DNA, including mutations and abnormal content of mitochondrial DNA (mtDNA), are associated with the initiation and development of acute lymphoblastic leukemia (ALL).The aim of this study was to explore association between mtDNA content in peripheral blood cells could be used as a risk predictor for ALL.
Looking for future studies?
Notify MeUp to 16 year
All sexes
Observational
Tianjin, Tianjin Municipality, 300000, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Mitochondria are responsible for multiple cellular functions including regulation of energy production, modulation of oxidation-reduction status, generation of reactive oxygen species and apoptosis. Each mitochondrion possesses multiple copies of a mitochondrial genome comprised of independently replicating double stranded DNA (mtDNA).
Time frame: From date of admission until the date of discharging from hospital, assessed up to 5 days
The ratio of mitochondrial DNA contents to hemoglobin contents was calculated for each sample from standard curves. After that, the ratio for each sample was normalized to a calibrator DNA in order to standardize between different runs, and then defined as the measurement of relative mtDNA contents.Relative expression of mtDNA were measured in young adults suffered from chronic lymphocytic leukemiawhen compared with control group.
Air Force Military Medical University, China
Other
Association Between Mitochondrial DNA Content and Risk of Acute Leukemia in Young Adult
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06810583
Acute Myeloid Leukemia, Hematologic Diseases
Memphis, Tennessee, United States
View Trial DetailsNCT06099366
Lymphoblastic Leukemia in Children
Seoul, Other (Non U.s.), South Korea
View Trial DetailsNCT05648019
B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma
Singapore
View Trial DetailsNCT05043571
CAR, CAR T-Cell-Related Encephalopathy Syndrome
Singapore
View Trial Details